Picture of Orexo AB logo

ORX Orexo AB Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue845664565624639
Cost of Revenue
Gross Profit739598486522550
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses614684779808748
Operating Profit231-19.9-214-184-110
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes228-38.3-223-170-140
Provision for Income Taxes
Net Income After Taxes219-84.4-224-178-128
Net Income Before Extraordinary Items
Net Income219-84.4-224-178-128
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income219-84.4-224-178-128
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS6.20.861-0.654-1.9-1.45
Dividends per Share